News
-
Decision 9C_672/2021 dated 19 July 2023
-
Swissmedic Journal 07/2023
-
Swissmedic gains accreditation for Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP) in the field of advanced therapy medicinal products (ATMPs)
-
Swissmedic participation in the European Medicines Agency (EMA) OPEN initiative
-
Decision 9C_256/2023 dated 18 July 2023
-
New blood donation criteria for men who have sex with men
-
Establishment licence for Dr. Heinz Welti AG – Suspension of establishment licence at Bubendorf site lifted
-
MRA between Switzerland and the USA on the manufacturing practice for medicinal products takes effect
-
First RSV vaccine to protect infants up to 6 months of age and older adults
-
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 17 – 20 July 2023
-
Paving the way towards coordinated clinical trials in public health emergencies in the EU
-
Pfizer AG submits authorisation application for coronavirus vaccine Comirnaty XBB.1.5
-
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 11 – 13 July 2023
-
European Health Union – EU steps up action to prevent shortages of antibiotics for next winter
-
Reflection paper on the use of artificial intelligence in the lifecycle of medicines
-
OPEN framework extended to a wider range of medicines
-
Triennial review of medicines’ SL prices – Lessons learned from appeals won against the FOPH
-
Swissmedic issues warning about falsified Ozempic pens
-
Public Consultation on ICH Reflection Paper launched in Switzerland
-
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 3 – 6 July 2023
-
Moderna submits authorisation application for coronavirus vaccine Spikevax XBB.1.5